Tuesday, 7 February 2012

USFDA: Abbreviated New Drug Application (ANDA) Approvals November 2011


Drug Name
and
FDA Appl
TRANEXAMIC ACID
BIONICHE PHARMA
11/03/2011
TIAGABINE HYDROCHLORIDE
SUN PHARM INDS
11/04/2011
RISPERIDONE
JUBILANT ORGANOSYS
11/04/2011
MYCOPHENOLATE MOFETIL
ALKEM LABS LTD
11/04/2011
FELODIPINE
ENDO PHARMS
11/04/2011
LEVOCETIRIZINE DIHYDROCHLORIDE
SYNTHON PHARMS
11/07/2011
NAPROXEN
AUROBINDO PHARMA USA
11/08/2011
CARBOPLATIN
ONCO THERAPIES LTD
11/09/2011
ACETAMINOPHEN; CODEINE PHOSPHATE
VINTAGE PHARMS
11/10/2011
MORPHINE SULFATE
WATSON LABS
11/10/2011
CILASTATIN SODIUM; IMIPENEM
HOSPIRA INC
11/16/2011
CILASTATIN SODIUM; IMIPENEM
HOSPIRA INC
11/16/2011
EPROSARTAN MESYLATE
MYLAN PHARMS INC
11/16/2011
LAMIVUDINE
AUROBINDO PHARMA LTD
11/17/2011
TRANEXAMIC ACID
VERSAPHARM INC
11/17/2011
SODIUM PHENYLBUTYRATE
AMPOLGEN
11/18/2011
LEFLUNOMIDE
ALEMBIC PHARMS LTD
11/21/2011
ETHINYL ESTRADIOL; LEVONORGESTREL
VINTAGE PHARMS
11/23/2011
CARBOPLATIN
ONCO THERAPIES LTD
11/23/2011
CARBAMAZEPINE
APOTEX INC
11/25/2011
ENOXAPARIN SODIUM
SANDOZ INC
11/28/2011
DROSPIRENONE; ETHINYL ESTRADIOL
WATSON LABS
11/28/2011
TRAMADOL HYDROCHLORIDE
ALVOGEN
11/28/2011
FELODIPINE
TORRENT PHARMS LTD
11/28/2011
RISPERIDONE
PRINSTON INC
11/29/2011
ATORVASTATIN CALCIUM
RANBAXY LABS LTD
11/30/2011
MINOCYCLINE HYDROCHLORIDE
LUPIN LTD
11/30/2011

No comments:

Post a Comment